Advanced Proteome Therapeutics Corporation
650 Albany Street
Suite 113
Boston
Massachusetts
02118
United States
Tel: 617-638-0340
Fax: 617-638-0341
Website: http://www.advancedproteome.com/
Email: akrantz@advancedproteome.com
17 articles about Advanced Proteome Therapeutics Corporation
-
Advanced Proteome Therapeutics and ImmunoBiochem Corporation Enter Into a Collaboration and Option Agreement
2/7/2018
The companies will evaluate the prospect of combining ImmunoBiochem’s proprietary antibody and APC’s site-selective conjugation technology to produce ADCs with superior properties, targeting triple-negative breast cancer.
-
Heidelberg Pharma AG and Advanced Proteome Therapeutics Progress Collaborative Program
1/9/2018
The companies have agreed to test the combination of APC's proprietary site-selective protein modification technology and Heidelberg Pharma's proprietary ATAC technology in order to generate superior cancer therapeutics.
-
Advanced Proteome Therapeutics Corporation Announces Collaboration To Develop Cancer Therapeutic
7/18/2017
-
Advanced Proteome Therapeutics Corporation Enters Into Agreement With Major Global Pharmaceutical Company
11/15/2010
-
Advanced Proteome Therapeutics Corporation to Be Granted Patent by EPO and to Present at Premier Biopartnering and Investment Conference
3/2/2010
-
Advanced Proteome Therapeutics Corporation Files Patent Application on Swift Linkage Multivalent Technology
10/20/2009
-
Advanced Proteome Therapeutics Corporation Enters Into Investor Relations Agreement
8/10/2009
-
Advanced Proteome Therapeutics Corporation Announces Advances in Technology in 3rd Quarter Filing, Grants Stock Options, and Ends Investor Relations Agreement
6/26/2009
-
Advanced Proteome Therapeutics Corporation with Atreus Pharmaceuticals, Inc. Advance Annexin V Conjugates for Diagnostic Imaging and Research Use
3/23/2009
-
Advanced Proteome Therapeutics Corporation Grants Stock Options
3/11/2009
-
Advanced Proteome Therapeutics Corporation: Appointment of Chief Financial Officer
3/10/2009
-
Advanced Proteome Therapeutics Corporation Announces Board Resignations and Audit Committee Chairman Appointment
11/19/2008
-
Advanced Proteome Therapeutics Corporation Makes Major Advance in Technology Development
11/17/2008
-
Advanced Proteome Therapeutics Corporation to Terminate SEC Reporting Obligations
10/22/2008
-
Advanced Proteome Therapeutics Corporation Announces Achievement of a Milestone
5/2/2008
-
Advanced Proteome Therapeutics Corporation: Company Targets Off-Patent, High Value, Protein Therapeutics in 20-F Filing
2/22/2008
-
Advanced Proteome Therapeutics Corporation and Atreus Pharmaceuticals, Inc. Announce Strategic R&D Agreement
11/5/2007